Clinical Guest Contributors
-
Donating Surplus Clinical Trial Supplies Is Sustainability’s “Low-Hanging Fruit”
1/29/2024
ClinOps professionals know all too well the waste that occurs with leftover trial kits that are destroyed at the end of the trial. Explore donation as a way to give those kits a second life.
-
Ensuring Diversity And Accessibility In Neurological Research
1/26/2024
The landscape of neurological and rare disorders is as diverse as the human population it affects. Yet, clinical trials for these conditions have not always mirrored this diversity.
-
FDA Draft Guidance On “Rare Diseases: Considerations For The Development Of Drugs And Biological Products”
1/26/2024
Accenture Applied Life Science Solutions' Raj Bandaru, Ph.D. breaks down, summarizes, and shares detailed insight on the recent FDA Draft Guidance that addresses “Rare Diseases: Considerations for the Development of Drugs and Biological Products.”
-
3 Ways Biotechs Can Lower The Cost Of Clinical Trials
1/23/2024
LongeVC has identified three innovative models to help biotechs lower the cost of their clinical trials.
-
Objectively Evaluating Innovative Therapies And Making Sense Of Emerging Data
1/22/2024
Poseida Therapeutics' President and CEO, Kristin Yarema, Ph.D., details why allogenic CAR-T compares favorably with autologous CAR-T, and why, in many ways, allo has advantages that auto cannot hope to match.
-
Quick Tips And Hot Takes For Selecting Clinical Trial Technology
1/22/2024
Avoid inefficient decision-making that keeps key downstream activities in limbo and select a new clinical trial technology efficiently with this technology selection guide.
-
Understanding Precision Neuroscience As Treatment For Rare Autoantibody Disease
1/19/2024
J&J Innovative Medicine develops precision therapeutics in neuroscience, reducing the trial participation and treatment burdens on people living with generalized myasthenia gravis.
-
Balancing TMF Management After A Mass Layoff
1/16/2024
Discover nine next steps for you and your TMF team to help address the uncertainty of layoffs and maintain an accurate and up-to-date trial master file.
-
Patient Engagement Needs More Benefit Analysis, Fewer Theoretical Conversations
1/12/2024
Are companies just tagging on to the status quo of being “patient-centric” without fully analyzing the return on investment for their company? Consultant and patient advocate Ella Balasa discusses.
-
Why — And How — To Improve Adherence To Treatment In Clinical Trials
1/12/2024
In part two of this series, discover the benefits of adherence to treatment, as well as immediate ways to leverage current services, tools, and resources to improve patient adherence.